Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Paying user area
Try for free
Allergan PLC pages available for free this week:
- Income Statement
- Analysis of Short-term (Operating) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value (EV)
- Enterprise Value to EBITDA (EV/EBITDA)
- Capital Asset Pricing Model (CAPM)
- Return on Assets (ROA) since 2005
- Current Ratio since 2005
- Price to Earnings (P/E) since 2005
- Price to Operating Profit (P/OP) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Allergan PLC for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).
Balance sheet item | Description | The company |
---|---|---|
Current liabilities | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. | Allergan PLC current liabilities as a percentage of total liabilities and equity decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level. |
Long-term liabilities | Amount of obligation due after one year or beyond the normal operating cycle, if longer. | Allergan PLC long-term liabilities as a percentage of total liabilities and equity increased from 2017 to 2018 but then decreased significantly from 2018 to 2019. |
Total liabilities | Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. | Allergan PLC total liabilities as a percentage of total liabilities and equity decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level. |
Shareholders’ equity | Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. | Allergan PLC shareholders’ equity as a percentage of total liabilities and equity increased from 2017 to 2018 but then decreased significantly from 2018 to 2019. |